Detalhe da pesquisa
1.
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
N Engl J Med
; 386(3): 220-229, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045228
2.
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.
J Infect Dis
; 228(10): 1452-1455, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540090
3.
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.
Gastroenterology
; 160(1): 115-127.e30, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763240
4.
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Clin Infect Dis
; 72(12): 2132-2140, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32255488
5.
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.
J Infect Dis
; 214(2): 173-81, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908752
6.
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.
Cancer Discov
; : OF1-OF15, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588588
7.
Drugging the microbiome and bacterial live biotherapeutic consortium production.
Curr Opin Biotechnol
; 78: 102801, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228531
8.
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool.
Open Forum Infect Dis
; 9(9): ofac448, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36158136
9.
Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
Biotechnol Prog
; 23(5): 1210-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17715941
10.
Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses.
Hum Gene Ther
; 14(10): 1017-34, 2003 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12869219
11.
Quantitative studies of cell-bubble interactions and cell damage at different pluronic F-68 and cell concentrations.
Biotechnol Prog
; 20(4): 1183-91, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15296446
12.
Fluid mechanics, cell distribution, and environment in CellCube bioreactors.
Biotechnol Prog
; 19(1): 2-8, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12572999
13.
Biochemical engineering.
Curr Opin Biotechnol
; 15(5): 441-3, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15464375
14.
293 cell cycle synchronisation adenovirus vector production.
Biotechnol Prog
; 25(1): 235-43, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19199366
15.
Vaccine Technology III: an ECI Conference held in Puerto Vallarta, Mexico from June 6-11, 2010.
Vaccine
; 29(41): 7115-6, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21689708
16.
Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector.
Biotechnol Bioeng
; 90(5): 645-55, 2005 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15834950
17.
Production and formulation of adenovirus vectors.
Adv Biochem Eng Biotechnol
; 99: 193-260, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16568893
18.
Production of core and virus-like particles with baculovirus infected insect cells.
Adv Biochem Eng Biotechnol
; 74: 183-206, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11991179
19.
Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions.
Biotechnol Bioeng
; 80(5): 569-79, 2002 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-12355468
20.
Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
Biotechnol Bioeng
; 83(1): 45-52, 2003 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-12740932